Menstrual Blood‑Derived Endometrial Stem Cells Protect the Integrity of the Intestinal Barrier by Inhibiting the NF‐κB/Snail Signaling Pathway
Cell Biology International · 2025
DOI: 10.1002/cbin.70040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology International, 2025. Verfasst von Tao Ruan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell and Biotherapy Engineering Research Center of Henan, College of Life Science and Technology, Xinxiang Medical University, Xinxiang, China. Hauptthemen laut MEDLINE: Snail Family Transcription Factors, NF-kappa B, Intestinal Mucosa, Endometrium. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: This study was supported by the Scientific and Technological Foundation of Henan Province in China (222102310382), Key Research Projects in the Colleges of Hen….
Abstract (Originalsprache)
Inflammatory bowel diseases (IBDs), including Crohn's disease (CD) and ulcerative colitis (UC) are chronic recurrent nonspecific intestinal disease. Current IBD therapeutics cannot fundamentally change the natural course of IBD. Therefore, it is of great significance to find new treatment strategies for IBD. Preclinical and clinical studies have shown that mesenchymal stem cells (MSCs) are a promising therapeutic approach. However, the mechanism by which MSCs alleviate colitis and how MSCs affect intestinal mucosal barrier is still unclear. LPS‐exposed human colonic epithelial cancer cell lines Caco2 and HT29. Dextran sulfate sodium (DSS)‐induced IBD mouse were treated with MenSCs. We found that LPS downregulates intercellular junction proteins and induces the production of inflammatory cytokines in intestinal epithelial cells. MenSCs reduced paracellular permeability and restored barrier integrity in Caco2 cells. In Vivo, MenSCs mitigated DSS‐induced colitis in mice by reducing body weight loss, colonic shortening, and disease activity index scores and by inhibiting the expressions of the pro‐inflammatory cytokines IL‐1β, IL‐6, and TNF‐α. MenSCs increased the expression of TJ proteins, improved the destruction of tight junction (TJ) structures, and reduced intestinal epithelial permeability. Furthermore, MenSCs could inhibit NF‐κB p65 phosphorylation and the expression of Snail and prevent Snail nuclear localization, thereby maintaining tight and adherens junctions. Our findings demonstrate that MenSCs alleviate intestinal inflammation and enhance barrier function by suppressing the NF‐κB/Snail signaling axis, offering a promising therapeutic strategy for inflammatory bowel diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stem Cell and Biotherapy Engineering Research Center of Henan, College of Life Science and Technology, Xinxiang Medical University, Xinxiang, China.
- Henan Joint International Research Laboratory of Stem Cell Medicine, School of Medical Engineering, Xinxiang Medical University, Xinxiang, China.
- School of Public Health, Xinxiang Medical University, Xinxiang, China.
ORCID-Profile: Juntang Lin
Förderung
- This study was supported by the Scientific and Technological Foundation of Henan Province in China (222102310382), Key Research Projects in the Colleges of Hen…
Zitieren
APA
Ruan, T., Han, J., Xue, C., Liang, H., & Lin, J. (2025). Menstrual Blood‑Derived Endometrial Stem Cells Protect the Integrity of the Intestinal Barrier by Inhibiting the NF‐κB/Snail Signaling Pathway. Cell Biology International. https://doi.org/10.1002/cbin.70040
Vancouver
Ruan T, Han J, Xue C, Liang H, Lin J. Menstrual Blood‑Derived Endometrial Stem Cells Protect the Integrity of the Intestinal Barrier by Inhibiting the NF‐κB/Snail Signaling Pathway. Cell Biology International. 2025. doi:10.1002/cbin.70040
BibTeX
@article{Ruan2025,
author = {Ruan, Tao and Han, Jiaming and Xue, Chengxu and Liang, Haiyan and Lin, Juntang},
title = {Menstrual Blood‑Derived Endometrial Stem Cells Protect the Integrity of the Intestinal Barrier by Inhibiting the NF‐κB/Snail Signaling Pathway},
journal = {Cell Biology International},
year = {2025},
doi = {10.1002/cbin.70040}
}
EUVIMED